Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Darzalex
Pharma
Orphan drug sales to surge past $400B in 2032: report
Despite a few recent policy wins, the orphan drug market remains vulnerable to a more scrutinizing FDA and potential pricing pressures.
Angus Liu
Mar 12, 2026 8:20am
J&J chief Joaquin Duato collects sizable pay raise for 2025
Mar 11, 2026 10:55am
Tecvayli-Darzalex combo earns national priority nod from FDA
Mar 6, 2026 8:00am
Quadruplet Darzalex regimen bags new myeloma nod
Jan 28, 2026 8:55am
J&J expects revenue to reach $100B in 2026 amid Darzalex surge
Jan 21, 2026 12:01pm
Johnson & Johnson's Tecvayli struts its stuff as a monotherapy
Jan 15, 2026 10:15am
